EZH2 and posterior cortical atrophy: Supporting this notion, three highly selective, SAM-competitive EZH2 inhibitors (CPI-1205, GSK126 and EPZ-6438) had much higher IC50 values in chemoresistant PCa cells and did not affect major components of the putative noncanonical EZH2 signaling (Figure S8).